Significant disease burden in paroxysmal nocturnal haemoglobinuria (PNH) patients with lower levels of haemolysis, mild anaemia and minimal transfusion: clinical improvement with eculizumab therapy

被引：0
|
作者：
Hill, A. [1 ]
Bessler, M. [2 ]
Schrezenmeier, H. [3 ]
Maciejewski, J. P. [4 ]
Rollins, S. A. [5 ]
Young, N. S. [6 ]
Luzzatto, L. [7 ]
机构：
[1] Bradford Royal Infirm, Dept Haematol, Bradford, W Yorkshire, England
[2] Washington Univ, Sch Med, St Louis, MD USA
[3] Inst Clin Transfus Med & Immunogenet, Ulm, Germany
[4] Cleveland Clin, Cleveland, OH 44106 USA
[5] Alex Pharmaceut, Cheshire, CT USA
[6] NHLBI, Bethesda, MD 20892 USA
[7] Ist Toscano Tumori, Florence, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
180
引用
收藏
页码：66 / 67
页数：2
相关论文
共 14 条
  • [1] Significant disease burden in paroxysmal nocturnal hemoglobinuria patients with lower levels of hemolysis, mild anemia and minimal transfusion: Clinical improvement with eculizumab therapy.
    Bessler, Monica
    Schrezenmeier, Hubert
    Maciejewski, Jaroslaw P.
    Hill, Anita
    Rollins, Scott A.
    Young, Neal S.
    Luzzatto, Lucio
    BLOOD, 2007, 110 (11) : 257A - 258A
  • [2] Sustained control of haemolysis and symptoms and reduced transfusion requirements over a period of 2 years in paroxysmal nocturnal haemoglobinuria (PNH) with eculizumab therapy
    Hill, A
    Elebute, D
    Marsh, JC
    Richards, SJ
    Mcnutt, B
    Petro, BE
    Rother, RP
    Hillmen, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 81 - 82
  • [3] Low Level Residual Extravascular Haemolysis Is Common Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria(PNH), but Does Not Affect Transfusion Requirement
    Kulasekararaj, Austin G.
    Odunsi, Dupe
    Krishnamurthy, Pramila
    Janet, Hayden
    Momoh, Ibrahim
    Mufti, Ghulam J.
    Marsh, Judith C. W.
    Elebute, Modupe
    BLOOD, 2010, 116 (21) : 1721 - 1722
  • [4] Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry
    Almeida, Antonio M.
    Bedrosian, Camille
    Cole, Alexander
    Muus, Petra
    Schrezenmeier, Hubert
    Szer, Jeff
    Rosse, Wendell F.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (09) : 1026 - 1034
  • [5] Long term stability of red cell responses in patients with paroxysmal nocturnal haemoglobinuria (PNH) on eculizumab therapy: implications for the future treatment and management of PNH
    Richards, SJ
    Cullen, MJ
    Dickinson, AJ
    Hill, A
    Buchanon, D
    Arnold, L
    Elebute, M
    Rother, RP
    Hillmen, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 16 - 16
  • [6] Eculizumab, a C5 complement-blocking antibody, controls haemolysis in paroxysmal nocturnal haemoglobinuria (PNH) with responses maintained over a prolonged period of therapy
    Hillmen, P
    Hall, C
    Marsh, JCW
    Elebute, M
    Richards, SJ
    Rollins, SA
    Mojcik, CF
    Rother, RP
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 2 - 2
  • [7] Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
    Lee, Jong Wook
    Griffin, Morag
    Kim, Jin Seok
    Lee, Lily Wong Lee
    Piatek, Caroline
    Nishimura, Jun-ichi
    Infante, Cynthia Carrillo
    Jain, Deepak
    Liu, Peng
    Filippov, Gleb
    de Fontbrune, Flore Sicre
    Risitano, Antonio
    Kulasekararaj, Austin G.
    LANCET HAEMATOLOGY, 2023, 10 (12): : E955 - E965
  • [8] CLINICAL SYMPTOMS OF HEMOLYSIS ARE PREDICTIVE OF DISEASE BURDEN AND MORTALITY IN ASIAN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
    Lee, J. W.
    Jang, J. H.
    Lee, J. H.
    Yoon, S. S.
    Kim, J. S.
    Kim, Y. K.
    Cho, D. Y.
    Sohn, S. K.
    Chung, J. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 206 - 206
  • [9] Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
    Schrezenmeier, Hubert
    Roeth, Alexander
    Araten, David J.
    Kanakura, Yuzuru
    Larratt, Loree
    Shammo, Jamile M.
    Wilson, Amanda
    Shayan, Gilda
    Maciejewski, Jaroslaw P.
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1505 - 1514
  • [10] Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
    Hubert Schrezenmeier
    Alexander Röth
    David J. Araten
    Yuzuru Kanakura
    Loree Larratt
    Jamile M. Shammo
    Amanda Wilson
    Gilda Shayan
    Jaroslaw P. Maciejewski
    Annals of Hematology, 2020, 99 : 1505 - 1514
12